Schall Thomas J.'s Form 4 filing
ChemoCentryx, Inc. · filed Aug 8, 2022
- Accession no.
- 0001209191-22-044896
- Filed
- Aug 8, 2022
- Trade date
- Aug 4, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.53M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schall Thomas J.CIK 0001423084 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 | Common Stock | MOption exerciseAcquired | +130,000 | $14.28 | +$1,856,400 | 2,523,352 | Direct | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −130,000 | $50.24F2 | −$6,531,200 | 2,393,352 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 | Common Stock | MOption exerciseDisposed | −130,000 | –F4 | – | 35,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $50.05 to $50.59 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Not applicable.
Referenced by the price of 1 transaction in Table II.